文献速递外周动脉疾病主动脉疾病

双侧下肢流入道血运重建的杂交手术疗效分析

Hybrid surgery for bilateral lower extremity inflow revascularization.
PubMed 文献 · J Vasc Surg · 2019-03-02

基于美国外科医师学会国家手术质量改进计划2012-2015年数据,比较主-双股动脉旁路(ABF)、腋-双股动脉旁路(AXBF)与杂交手术(股-股旁路联合逆行腔内主髂动脉介入)的围手术期结局。倾向匹配后,杂交手术较ABF旁路肺炎、非计划插管、心脏骤停、输血及复合并发症均显著减少,死亡率、30天再手术率和住院时间也更低,但截肢与再入院无差异。

要点

  • 倾向匹配后杂交手术复合并发症32.6%,显著低于ABF旁路的55%。
  • 杂交手术死亡率1%、30天再手术率9.3%,均显著低于ABF旁路。
  • 杂交手术住院时间5.79±9.72天,显著短于ABF旁路的9.79±10.69天。

核心结论

  • ABF旁路仍是美国外科医师学会国家手术质量改进计划数据库中双侧下肢血运重建最常用的术式且结局良好。
  • 在选定患者中,杂交手术较ABF旁路与更优的围手术期30天结局相关。

研究设计与样本

  • 回顾性队列研究,基于美国外科医师学会国家手术质量改进计划2012至2015年文件。
  • 共纳入1426例患者,其中ABF旁路976例、AXBF旁路257例、杂交手术193例。
  • 进行倾向匹配分析比较杂交手术与ABF旁路,匹配后ABF旁路571例与杂交手术患者比较。
  • 统计方法包括χ2检验和方差分析事后分析,使用SPSS软件。

主要发现

  • 三组间年龄<70岁比例差异显著:ABF旁路84.2%、AXBF旁路49.8%、杂交手术58%(P < .001)。
  • 三组间独立生活能力比例差异显著:ABF旁路98%、AXBF旁路89.1%、杂交手术93.2%(P < .001)。
  • AXBF旁路组重症肢体缺血比例72.4%,高于ABF旁路46.5%和杂交手术51.8%(P < .001)。
  • 三组间死亡率无差异(P = .178)。
  • 倾向匹配后杂交手术肺炎1.6% vs ABF旁路8.7%(P < .001),非计划插管3.1% vs 7.7%(P = .032),心脏骤停0.5% vs 3.7%(P = .025),输血18.1% vs 44.4%(P < .001),复合并发症32.6% vs 55%(P < .001)。

临床怎么用

  • 对于需要双侧下肢流入道血运重建的选定患者,杂交手术可作为ABF旁路的替代选择以改善围手术期结局。
  • ABF旁路仍是最常用术式且结局良好,应根据患者特征个体化选择术式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aortobifemoral (ABF) bypass is the preferred method of bilateral inflow revascularization, with axillobifemoral (AXBF) bypass reserved for high-risk patients. Hybrid (HYB) surgery in the form of femorofemoral bypass and retrograde endovascular aortoiliac intervention is increasingly being used to achieve the same goal. This study compared the perioperative outcomes of HYB surgery with traditional surgery for bilateral inflow revascularization. METHODS: The American College of Surgeons National Surgical Quality Improvement Program files for the years 2012 to 2015 were reviewed, and all patients undergoing ABF bypass, AXBF bypass, and HYB surgery (femoral-femoral bypass and retrograde endovascular intervention) were included. Patients' demographics, comorbidities, and outcomes were compared between the three groups. A propensity-matched analysis was subsequently performed to compare HYB surgery with ABF bypass only. The χ2 test and analysis of variance with post hoc analysis were conducted to evaluate between-group differences in risk factors and outcomes. SPSS statistical software (IBM Corp, Armonk, NY) was used. RESULTS: There were 1426 patients (ABF bypass, 976; AXBF bypass, 257; HYB surgery, 193). There were significant differences in the three populations of patients, with ABF bypass patients significantly more likely to have age <70 years (ABF bypass, 84.2%; AXBF bypass, 49.8%; HYB surgery, 58%; P < .001) and more likely to be independent (ABF bypass, 98%; AXBF bypass, 89.1%; HYB surgery, 93.2%; P < .001). Patients undergoing AXBF bypass were significantly more likely to be treated for critical limb ischemia (ABF bypass, 46.5%; AXBF bypass, 72.4%; HYB surgery, 51.8%; P < .001) under emergent conditions (ABF bypass, 0.9%; AXBF bypass, 5.1%; HYB surgery, 3.6%; P < .001). There was no difference in mortality between the three groups (P = .178). After propensity matching, a total of 571 patients with ABF bypass were compared with HYB surgery patients. HYB surgery patients had significantly less pneumonia (ABF bypass, 8.7%; HYB surgery, 1.6%; P < .001), unplanned intubation (ABF bypass, 7.7%; HYB surgery, 3.1%; P = .032), cardiac arrest (ABF bypass, 3.7%; HYB surgery, 0.5%; P = .025), transfusion (ABF bypass, 44.4%; HYB surgery, 18.1%; P < .001), and composite morbidity (ABF bypass, 55%; HYB surgery, 32.6%; P < .001). Patients undergoing ABF bypass had significantly higher mortality (ABF bypass, 4.2%; HYB surgery, 1%; P = .043) and 30-day reoperation (ABF bypass, 17.5%; HYB surgery, 9.3%; P = .009) and longer total hospital length of stay (ABF bypass, 9.79 ± 10.69 days; HYB surgery, 5.79 ± 9.72 days; P < .001). There was no difference in major amputation (P = .607) and readmission (P = .495) between the two groups. CONCLUSIONS: ABF bypass is the most common surgery for bilateral lower extremity revascularization in the American College of Surgeons National Surgical Quality Improvement Program database and continues to have good outcomes. In selected patients, HYB surgery was associated with improved perioperative, 30-day outcomes compared with ABF bypass.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jorshery SD, Luo J, Zhang Y, et al. Hybrid surgery for bilateral lower extremity inflow revascularization. J Vasc Surg. 2019. PMID: 30837177. doi:10.1016/j.jvs.2018.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。